Search research articles
Contact Us
Filters
Showing results (161-170 of 197) with videos related to
Page
of 20
Sort By:
Frontiers in Immunology
|
July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Autoimmunity Reviews
|
March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Clinical and Experimental Rheumatology
|
January 11, 2021
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
Salvatore D'Angelo, Nazzarena Malavolta, Cinzia Scambi, et al.
Frontiers in Pharmacology
|
May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Arthritis Research & Therapy
|
September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Rheumatology (Oxford, England)
|
April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritis
Giuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Clinical and Experimental Rheumatology
|
December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
Giacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
Rheumatology International
|
June 5, 2026
Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)
Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
Scientific Reports
|
May 7, 2022
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis
Luca Navarini, Damiano Currado, Annalisa Marino, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry
Giuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 197) with videos related to
Sort By:
Page
of 20
Frontiers in Immunology
|
July 30, 2024
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Autoimmunity Reviews
|
March 23, 2024
The management of patients with inflammatory bowel disease-associated spondyloarthritis: Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Society of Rheumatology (SIR) recommendations based on a pseudo-Delphi consensus
Fabio Salvatore Macaluso, Flavio Caprioli, Laura Benedan, et al.
Clinical and Experimental Rheumatology
|
January 11, 2021
Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study
Salvatore D'Angelo, Nazzarena Malavolta, Cinzia Scambi, et al.
Frontiers in Pharmacology
|
May 15, 2026
Real-world clinical experience with upadacitinib in a cohort of Italian patients with axial spondyloarthritis
Roberta Ramonda, Mariagrazia Lorenzin, Antonio Carletto, et al.
Arthritis Research & Therapy
|
September 28, 2024
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort
Roberta Ramonda, Mariagrazia Lorenzin, Maria Sole Chimenti, et al.
Rheumatology (Oxford, England)
|
April 18, 2026
Phenotypic differences and treatment persistence in a large multicenter cohort of axial psoriatic arthritis
Giuseppe Lopalco, Sergio Del Vescovo, Michele Maria Luchetti, et al.
Clinical and Experimental Rheumatology
|
December 18, 2020
Efficacy and safety of baricitinib in 446 patients with rheumatoid arthritis: a real-life multicentre study
Giacomo Maria Guidelli, Ombretta Viapiana, Nicoletta Luciano, et al.
Rheumatology International
|
June 5, 2026
Clinical associations and related factors of metabolic syndrome in systemic sclerosis: results from an observational multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale)
Vasiliki Liakouli, Giulio Forte, Piero Ruscitti, et al.
Scientific Reports
|
May 7, 2022
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis
Luca Navarini, Damiano Currado, Annalisa Marino, et al.
Therapeutic Advances in Musculoskeletal Disease
|
February 3, 2025
Efficacy and retention rate of secukinumab in psoriatic arthritis across different clinical phenotypes: insights from the Italian GISEA Registry
Giuseppe Lopalco, Maria Morrone, Fabiola Atzeni, et al.
Page
of 20